Balyasny Asset Management’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-18,034
| Closed | -$2.38M | – | 1803 |
|
|
2018
Q4 | $2.38M | Buy |
18,034
+9,888
| +121% | +$1.27M | 0.02% | 675 |
|
|
2018
Q3 | $1.09M | Sell |
8,146
-399,127
| -98% | -$59.8M | ﹤0.01% | 1158 |
|
|
2018
Q2 | $64.8M | Buy |
407,273
+247,357
| +155% | +$36.7M | 0.29% | 79 |
|
|
2018
Q1 | $22.9M | Sell |
159,916
-301,748
| -65% | -$41.2M | 0.1% | 298 |
|
|
2017
Q4 | $61.4M | Buy |
461,664
+241,616
| +110% | +$30.9M | 0.19% | 135 |
|
|
2017
Q3 | $27.4M | Buy |
220,048
+108,619
| +97% | +$15M | 0.11% | 254 |
|
|
2017
Q2 | $15.7M | Buy |
111,429
+106,674
| +2,243% | +$13.3M | 0.06% | 393 |
|
|
2017
Q1 | $536K | Sell |
4,755
-45,823
| -91% | -$5.34M | ﹤0.01% | 1285 |
|
|
2016
Q4 | $5.32M | Sell |
50,578
-85,379
| -63% | -$9.18M | 0.03% | 671 |
|
|
2016
Q3 | $17.1M | Sell |
135,957
-13,792
| -9% | -$1.75M | 0.1% | 283 |
|
|
2016
Q2 | $20.7M | Buy |
149,749
+88,302
| +144% | +$11.7M | 0.13% | 204 |
|
|
2016
Q1 | $8.53M | Buy |
+61,447
| New | +$8.43M | 0.05% | 435 |
|
|
2015
Q4 | – | Sell |
-144,572
| Closed | -$19.3M | – | 1561 |
|
|
2015
Q3 | $19.3M | Buy |
+144,572
| New | +$18.9M | 0.14% | 196 |
|
Balyasny Asset Management's ATHN Position: Q1 2019 in Review
Balyasny Asset Management sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 18,034 shares — an estimated $2.38M sold.
Balyasny Asset Management first reported a position in ATHN in Q3 2015 and held it in 13 quarters. The position peaked at $64.8M in Q2 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.
- Balyasny Asset Management reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
- Balyasny Asset Management sold 18,034 Athenahealth, Inc. shares in Q1 2019, an estimated $2.38M.
- Balyasny Asset Management first reported a position in Athenahealth, Inc. in Q3 2015 and held it in 13 quarters.
- Balyasny Asset Management's Athenahealth, Inc. position peaked at $64.8M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.
Based on Balyasny Asset Management's 13F filing for Q1 2019, filed 15 May 2019.